Search Tag: Scientific Advisory Board
2023 12 Dec
Expertise from award-winning computational biologist, human immunologist and engineer with experience from Yale, NIH, and NIAID will help advance ImmunoScape’s machine learning capabilities ImmunoScape, a biotechnology company focused on next-generation immunotherapies, today announced the appointment of John Tsang, Ph.D. to its Scientific Advisory...Read more
2023 24 Jul
Specific Biologics is an early-stage biotechnology company developing its proprietary two-site Dualase® platform gene editors to build a pipeline of treatments for serious genetic diseases. Specific Biologics Inc., a venture-backed, early-stage genome editing company, is pleased to announce it has appointed Tirtha Chakraborty, Ph.D. and Mike Nicholson,...Read more
2023 14 Feb
Vial, a global CRO providing next-generation clinical trial management services, announced the addition of Dr. Rajat N Agrawal to Vial’s scientific advisory board (SAB). Dr. Agrawal, an ophthalmologist and retina specialist, will work closely with the company’s leadership team to enhance the scientific strategy of Vial’s Ophthalmology CRO products...Read more
2022 19 Dec
Carcell Biopharma, an EVX Ventures company, is pleased to announce Prof. Harvey Lodish as the Chair of the Scientific Advisory Board. He joins Prof. Jianzhu Chen of the Massachusetts Institute of Technology (MIT) and Dr. Hagop Youssoufian of Brown University on Carcell's Scientific Advisory Board to propel scientific advancement of its cell and gene...Read more
2022 11 Sep
Vial continues to expand its scientific advisory board with new member Dr. Paul Karpecki, who will act as a consultant to Vial’s Ophthalmology CRO . Dr. Karpecki is the Medical Director of Keplr Vision and Faculty Associate Professor at the University of Pikeville, Kentucky, College of Optometry. Dr. Karpecki has over 20 years of experience...Read more
2022 07 Sep
Imaging Endpoints (IE) announced that Dr. Antonio Fojo was chosen to join their Scientific Advisory Board, a global group of leading medical professionals appointed to provide strategic insight and imaging-related expertise for optimizing the opportunity to demonstrate efficacy in clinical trials. Dr. Fojo is currently a professor of medicine...Read more
2022 24 Jul
Dr. Antoni Ribas, an immuno-oncology pioneer, has joined Vial’s Oncology Scientific Advisory Board. Dr. Ribas, along with other members of the board, will advise Vial on the launch of their upcoming Oncology CRO . The Vial CRO’s mission is to reimagine clinical trials by delivering faster and higher quality trials through a powerful technology...Read more